ZYKADIA (ceritinib) Patient Assistance Program
Don’t let the high cost of brand ALK-targeted NSCLC therapy disrupt your treatment. We help eligible patients access Zykadia (ceritinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Zykadia (ceritinib) is FDA-approved for ALK-positive metastatic non-small cell lung cancer (NSCLC) as first-line treatment or for patients who have progressed on or are intolerant to crizotinib. ALK inhibitor.
- Without assistance, Zykadia costs commonly run approximately $16,000–$20,000 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Zykadia for a flat $69.95 per month.
- There is no generic Zykadia. Other ALK inhibitors: crizotinib (Xalkori — older), alectinib (Alecensa — preferred first-line ALK NSCLC in most guidelines), brigatinib (Alunbrig), lorlatinib (Lorbrena — newest, broadest activity including CNS).
What Is Zykadia Prescription Assistance Program?
Zykadia PAP for ALK+ NSCLC patients.
Eligibility, oncology coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Zykadia $16,000–$20,000/month. PAP can help:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$19,500 | Save substantially |
| CVS Pharmacy (brand) | ~$20,000 | Save substantially |
| Walmart (brand) | ~$16,500 | Save substantially |
| Costco (brand) | ~$16,200 | Save substantially |
Specialty Pharmacy | ~$17,500 | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Zykadia Prescription Program?
PAP at no cost. Alectinib often preferred first-line over Zykadia per current guidelines.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Zykadia:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $16,000–$20,000 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Zykadia assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Zykadia Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Zykadia:
Zykadia (ceritinib) is once-daily oral ALK inhibitor for ALK-positive NSCLC. ALK rearrangements ~3–5% of NSCLC. Targeted therapy revolutionized ALK+ NSCLC care.
How Zykadia Works:
ALK fusion proteins cause constitutive kinase activity driving cancer. ALK inhibitors block the kinase activity.
Ceritinib is second-generation ALK inhibitor — broader activity against ALK resistance mutations than crizotinib (first-generation). Alectinib (third-generation, even broader spectrum and better CNS penetration) is generally preferred first-line per ALEX trial.
Form and use:
Zykadia 450 mg once daily with food (reduces GI toxicity). Until disease progression or unacceptable toxicity.
Generic availability:
No generic. ALK inhibitor options: Xalkori (crizotinib), Alecensa (alectinib — generally first-line), Alunbrig (brigatinib), Lorbrena (lorlatinib).
Warnings:
Severe GI toxicity (nausea, vomiting, diarrhea — often dose-limiting; taking with food reduces), hepatotoxicity (LFT monitoring), interstitial lung disease/pneumonitis, QT prolongation, bradycardia, hyperglycemia, pancreatitis.
FAQ (Frequently Asked Questions)
Cost?
$16,000–$20,000/month. Annual $200,000+.
Why not Alecensa first?
Alectinib (Alecensa) generally preferred first-line ALK+ NSCLC per ALEX trial — better progression-free survival, CNS efficacy, tolerability. Zykadia is alternative. Lorlatinib (newest, broadest) increasingly first-line.
Take with food?
Yes — 450 mg dose with food. Lower fasted dose (750 mg) was original FDA-approved but caused more GI toxicity; with-food protocol now standard.
Resistance?
Diarrhea is one of the most common Tykerb side effects, especially with capecitabine. Start loperamide at the first sign of diarrhea — keep loperamide on hand from the start. Stay hydrated. Severe or persistent diarrhea may require dose reduction or temporary discontinuation. Tell your oncologist about diarrhea that lasts more than 24 hours despite loperamide or is associated with fever, blood, or dizziness.
Denied?
Alectinib, brigatinib, lorlatinib — other ALK inhibitors with own PAPs. LUNGevity, PAN Foundation.
Take Control of Your Medication Costs
If facing Zykadia cost, alternative ALK inhibitors and PAP help. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.